ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2014
The Edmonton Symptom Assessment System (ESAS) as a screening tool for depression and anxiety in non-advanced patients with solid or haematological malignancies on cure or follow-up.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03266276 (Assessing the Impact of Cancer Care Ontario's Psychosocial Oncology & Palliative Care Pathway in Ambulatory Head and Neck Cancer Clinics), which is not on this map. Cited by 18 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Assessing the Impact of Cancer Care Ontario's Psychosocial Oncology & Palliative Care Pathway in Ambulatory Head and Neck Cancer Clinics
Who cites it
18 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Guideline
- Self-administered Meditation Application Intervention for Cancer Patients With Psychosocial Distress: A Pilot Study.Integrative cancer therapiesTrial
- Assessment of the Edmonton Symptom Assessment System depression item accuracy for classifying depression severity in individuals with cancer and pain.Scientific reports · 2026Article
- Standing the test of time: diagnostic accuracy of the Edmonton Symptom Assessment System-Revised (ESAS-r) for anxiety and depression screening.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026Article
- Using the Edmonton Symptom Assessment System (ESAS) to Describe Symptom Burden Associated with Breast Cancer and Related Treatments: A Cross-Sectional Study.Current oncology (Toronto, Ont.) · 2025Article
- Rehabilitation needs prior to adjuvant chemotherapy in a rural Swedish population.Journal of rehabilitation medicine · 2025Article
- Emergency palliative cancer care: anxiety and midazolam.BMC palliative care · 2025Article
- Routine symptom screening and supportive care needs.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2025Article
- Assessment of depression symptoms among cancer patients: a cross-sectional study from a developing country.Scientific reports · 2024Article
- Assessing the Impact of Organ Failure and Metastases on Quality of Life in Breast Cancer Patients: A Prospective Study Based on Utilizing EORTC QLQ-C30 and EORTC QLQ-BR45 Questionnaires in Romania.Journal of personalized medicine · 2024Article
- Psychological assessment and the role of the psychologist in early palliative care.Frontiers in psychology · 2024Article
- Factors associated with palliative care symptoms in cancer patients in Palestine.Scientific reports · 2023Article
- Assessing suffering of patients on cancer treatment and of those no longer treated using ESAS-Total Care (TC).Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023Article
- The pattern of change in opioid and adjuvant prescriptions for cancer pain before and after referral to a comprehensive program in the Palliative Care Center in Kuwait.BMC palliative care · 2021Article
- Screening Performance of Edmonton Symptom Assessment System in Kidney Transplant Recipients.Journal of clinical medicine · 2020Article
- Construction of new personal meanings by cancer patients: a qualitative analysis in an Italian patient population.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2019Article
- Development and evaluation of screening dysphagia tools for observational studies and routine care in cancer patients.Health science reports · 2018Article
- A modified Edmonton Symptom Assessment Scale for symptom clusters in radiation oncology patients.Cancer medicine · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSymptoms' assessment should be considered a clinical practice routine in all cancer stages. The Edmonton Symptom Assessment System (ESAS) is a ten-item patient-rated symptom assessment developed and validated for population affected by cancer in different languages and cultures. The main objective of this study was to assess the performance of ESAS items on anxiety and depression when detecting Hospital Anxiety Depression Scale (HADS) 'cases'.
methodsA cross-sectional study was carried out on 194 non-advanced patients with solid (108) or hematologic malignancies on cure or follow up, Karnofsky Performance Status ≥ 70, life expectancy > 6 months and no metastases. Patients were assessed by means of ESAS and by HADS. Receiving operator characteristic (ROC) analysis of ESAS anxiety and depression items versus cases of severe (cutoff 11) anxiety and depression according to HADS-specific subscales was performed.
resultsDepression and anxiety ESAS items correlated strongly (0.707, Spearman). Area under the curve ranged between 0.84 and 0.96 for the two ESAS items when detecting severe anxiety or depression HADS cases (cutoff = 11). ESAS anxiety or depression scores >3 detected quite well the severe depression HADS cases (Sensibility = 75-Specificity = 84, Sensibility = 87-Specificity = 90, respectively).
conclusionsAnxiety or depression ESAS items score >3 can be applied as a useful, easy and not time consuming screening tool for assessing anxiety and depression in non-advanced patients with solid or haematological malignancies.
Indexed as
Identifiers
24276952What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.